Skip to content

Study of Stability Evaluation and Risk Prediction Model Construction among Vertebrobasilar Dissecting Aneurysm Patients based on One-Stop Multimodal High Resolution Magnetic Resonance Imaging

Study of Stability Evaluation and Risk Prediction Model Construction among Vertebrobasilar Dissecting Aneurysm Patients based on One-Stop Multimodal High Resolution Magnetic Resonance Imaging

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089111
Enrollment
Unknown
Registered
2024-09-02
Start date
2023-03-23
Completion date
Unknown
Last updated
2024-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vertebrobasilar Dissecting Aneurysm

Interventions

Stable group:One-stop multimodal high-resolution magnetic resonance imaging findings suggestive of stable patients with unruptured VBDAs.
Unstable group:One-stop multimodal high-resolution magnetic resonance imaging findings suggestive of unstable patients with unruptured VBDAs.

Sponsors

Beijing Tiantan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged =18 years and =75 years; 2. Patients with a clinical diagnosis of "unruptured VBDAs"; 3. Patients with a baseline mRS score of 0; 4. Volunteering to participate in the study and signing the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Non-VBDAs (mainly bifurcation saccular aneurysms); 2. Patients with a combination of other serious systemic diseases at the time of diagnosis, with an expected survival time of less than 1 year; 3. Patients with other serious disease at diagnosis that would significantly interfere with follow-up; 4. Patients with symptoms related to the target aneurysm at the time of diagnosis, with an mRS score of =1; 5. Patients with other intracranial aneurysms; 6. CT/MRI showing intracranial hemorrhage or SAH (SWI microhemorrhage ignored); 7. Patients with severe allergy to gadolinium agents (rash ignored); 8. Patients with known dementia or psychiatric disorders and claustrophobia who are unable to complete the MRI and follow-up; 9. Patients who are participating in clinical trials of other drugs or devices.

Design outcomes

Primary

MeasureTime frame
Neurological function score;Perioperative complications;

Secondary

MeasureTime frame
Rate of complete occlusion of aneurysms at follow-up;Aneurysm size at follow-up;

Countries

China

Contacts

Public ContactLv Ming

Beijing Tiantan Hospital, Capital Medical University

dragontiger@163.com+86 137 0137 6177

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026